Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hypoxic Tumours”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Enrolling By InvitationNCT03054792
What this trial is testing

Molecular-Functional Imaging of Hypoxia in Childhood Sarcomas

Who this might be right for
RhabdomyosarcomaNon-Rhabdo. Soft Tissue Sarcoma
The Hospital for Sick Children 18
Testing effectiveness (Phase 2)Study completedNCT03003637
What this trial is testing

ImmunoModulation by the Combination of Ipilimumab and Nivolumab Neoadjuvant to Surgery In Advanced or Recurrent Head and Neck Carcinoma

Who this might be right for
ImmunotherapyHead and Neck Neoplasms
The Netherlands Cancer Institute 33
Not applicableEnded earlyNCT00430079
What this trial is testing

Use of EF5 to Measure the Oxygen Level in Tumor Cells of Patients Undergoing Surgery or Biopsy for Newly Diagnosed Supratentorial Malignant Glioma

Who this might be right for
Adult Anaplastic AstrocytomaAdult Anaplastic EpendymomaAdult Anaplastic Oligodendroglioma+11 more
National Cancer Institute (NCI) 48
Not applicableLooking for participantsNCT06108089
What this trial is testing

Novel Hypoxia Imaging for Head and Neck Cancer: Imaging Phenotype for Personalized Treatment

Who this might be right for
Head and Neck CancerHypoxiaMagnetic Resonance Imaging+1 more
University of Utah 20
Not applicableActive Not RecruitingNCT06685848
What this trial is testing

Comparison of Hemanext ONE® System and Conventional Red Blood Cell Transfusion

Who this might be right for
Hematologic Neoplasms
Hemanext 24
Testing effectiveness (Phase 2)Active Not RecruitingNCT03323463
What this trial is testing

Major De-escalation to 30 Gy for Select Human Papillomavirus Associated Oropharyngeal Carcinoma

Who this might be right for
HPV-Associated Oropharyngeal Squamous Cell CarcinomaSquamous Cell Carcinoma of the Neck
Memorial Sloan Kettering Cancer Center 316
Not applicableLooking for participantsNCT05500612
What this trial is testing

MRI Hypoxia Study for Glioblastoma Multiforme (GBM) Radiation Therapy

Who this might be right for
Glioblastoma Multiforme
University of Sydney 20
Not applicableActive Not RecruitingNCT01464216
What this trial is testing

MRI for Assessment of Hypoxia-Induced Prostate Cancer Aggressiveness

Who this might be right for
Prostatic NeoplasmsGenital Neoplasms, MaleProstatic Diseases
Oslo University Hospital 120
Testing effectiveness (Phase 2)Study completedNCT04338867
What this trial is testing

Nitroglycerin Plus Intracranial Radiotherapy for Brain Metastases in NSCLC Patients

Who this might be right for
Phase II Clinical TrialNinety-six Histologically Confirmed NSCLC Patients With BMRandomized 1:1 to Received TN Plus WBR or Only WBR+1 more
Instituto Nacional de Cancerologia de Mexico 96
Testing effectiveness (Phase 2)UnknownNCT01576796
What this trial is testing

Radiotherapy Dose Complement in the Treatment of Hypoxic Lesions Patients With Stage III Non-small-cell Lung Cancer

Who this might be right for
Stage III Non-small-cell Lung Cancer
Centre Henri Becquerel 75
Not applicableStudy completedNCT05030870
What this trial is testing

Capnographic Monitoring in Gastrointestinal Endoscopy for Elderly Patients

Who this might be right for
HypoxiaGastric CancerGastric Polyp+3 more
RenJi Hospital 1,800
Very early researchStudy completedNCT00884520
What this trial is testing

An Exploratory, Open Label, Multi-Center, Non-Randomized Study of [F-18]VM4-037

Who this might be right for
Lung CancerSquamous Cell CarcinomaHead and Neck Cancer+2 more
Siemens Molecular Imaging 16
Early research (Phase 1)Study completedNCT00588276
What this trial is testing

Pilot Evaluation of 124I-Iodo-Azomycin Galacto-Pyranoside (*IAZGP) Positron Emission Tomography (PET) in the Imaging of Hypoxic Tumors

Who this might be right for
Cervical CancerHEENT CancerRenal Cancer+3 more
Memorial Sloan Kettering Cancer Center 15
Testing effectiveness (Phase 2)Active Not RecruitingNCT03634540
What this trial is testing

A Trial of Belzutifan (PT2977, MK-6482) in Combination With Cabozantinib in Patients With Clear Cell Renal Cell Carcinoma (ccRCC) (MK-6482-003)

Who this might be right for
Renal Cell Carcinoma (RCC)Clear Cell Renal Cell Carcinoma (ccRCC)Kidney Cancer+6 more
Peloton Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 118
Not applicableStudy completedNCT06636448
What this trial is testing

The Relationship Between Body Mass Index and Patient Outcomes in Low Flow Anaesthesia

Who this might be right for
Major Gynecological Cancer SurgeryLow Flow Anesthesia
Bakirkoy Dr. Sadi Konuk Research and Training Hospital 40
Early research (Phase 1)Study completedNCT01017133
What this trial is testing

Fluorine F18-EF5 and Fludeoxyglucose F18 Positron Emission Tomography in Assessing Hypoxia and Glycolysis in Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Abramson Cancer Center at Penn Medicine 56
Not applicableEnded earlyNCT01934114
What this trial is testing

NIR Hypoxia Imaging of Breast Tumor Response to Neoadjuvant Chemotherapy in Vivo

Who this might be right for
Breast Cancer
Dartmouth-Hitchcock Medical Center 8
Not applicableWithdrawnNCT01210131
What this trial is testing

Hypoxia-guided Radiotherapy With Cisplatin-etoposide in Stage I-III : Small Cell Lung Cancer(SCLC)

Who this might be right for
Small Cell Lung Cancer (SCLC)
Maastricht Radiation Oncology
Not applicableStudy completedNCT02519062
What this trial is testing

Role of FDG PET, Immune and Hypoxic Marker in NSCLC

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Istituto Clinico Humanitas 130
Very early researchWithdrawnNCT03548727
What this trial is testing

Pseudo-Simultaneous Imaging of Tumor Hypoxia and Proliferation in HNC Patients Using PET/CT

Who this might be right for
Head and Neck Cancer
Weill Medical College of Cornell University
Next Page